Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Undefined offset: 0 in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-content/themes/cri/single.php on line 10

Notice: Trying to get property 'name' of non-object in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-content/themes/cri/single.php on line 10
Ron's Immunotherapy Story - Cancer Research Institute
stdClass Object ( [getLoginUrlResponse] => stdClass Object ( [JSESSIONID] => 485F7CE7A4EBEA4C8D27E6CB444E7C18.app30110b [routing_id] => 00000000.app30110b [url] => https://give.cancerresearch.org/site/CRConsAPI;jsessionid=00000000.app30110b?NONCE_TOKEN=1B63EB0B332C7F793B2C652072E52F73 [token] => gyBf06fEkyaqbF4O6VKXWM_oiPW3q-vHwUBARJXS3FtJo2tLFQqFRyovVjQv5y1DXW32DcNgShgnIrYu3YdR6mlFA7ik-UmcvxoUpQw ) ) test

Immune to Cancer: The CRI Blog

Subscribe

Share

Ron’s Immunotherapy Story

CRI Staff

Colorectal Cancer |  Diagnosed 2015

Immunotherapy definitely changed my life.

Ron’s Story

In 2015, Ron was diagnosed with stage 4 colorectal cancer. He received traditional, but debilitating, chemotherapy treatment for nine months. He wasn’t able to eat or sleep, and his devastated wife, Maria, searched for other options. In 2016, after learning he carried a genetic mutation linked to Lynch syndrome, Ron began combination immunotherapy on a clinical trial at University of Pittsburgh Medical Center. He received a nivolumab (Opdivo), a PD-1 checkpoint inhibitor, and ipilimumab (Yervoy), a CTLA-4 checkpoint inhibitor. After the trial ended, Ron continued to receive the nivo/ipi combination treatment as part of routine care and was able to continue his life with no evidence of progression for two years.

“I am able to live on immunotherapy,” Ron explained.

UPDATE: Ron passed away in December 2018. His family feels grateful for the additional time and quality of life that immunotherapy provided Ron and hope that someday immunotherapy is considered a first-line therapy for more types of cancer.

Maria McDermott, Caregiver: That was part of the excitement of doing a clinical trial--knowing that what you were going through could help somebody else.

Read more:

This site is registered on wpml.org as a development site.